In light of the current outbreak of a novel coronavirus (2019–nCoV), ChemRxiv would like to share this collection of preprints* on COVID-19. Chemistry has a key role to play in understanding everything from viral structure to pathogenesis, isolation of vaccines and therapies, as well as in the development of materials and techniques used by basic […]

In light of the current outbreak of a novel coronavirus (2019–nCoV), ChemRxiv would like to share this collection of preprints* on COVID-19. Chemistry has a key role to play in understanding everything from viral structure to pathogenesis, isolation of vaccines and therapies, as well as in the development of materials and techniques used by basic researchers, virologists, and clinicians.

ChemRxiv is openly accessible, with no subscription fees for readers and no submission charges for authors. We encourage you to read and share this collection with colleagues and also invite you to share your research with a global community of scientists by posting your COVID-19 research on ChemRxiv.

A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry
Mohamed El-Tholoth, Haim H. Bau, and Jinzhao Song

***

Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface
Micholas Smith and Jeremy C. Smith

***

Homology Models of the Papain-Like Protease PLpro from Coronavirus 2019-nCoV
Martin Stoermer

***

COVID-19 Disease: ORF8 and Surface Glycoprotein Inhibit Heme Metabolism by Binding to Porphyrin
Wenzhong Liu and Hualan Li

***

Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations
Junjie Zou, Jian Yin, Lei Fang, Mingjun Yang, Tianyuan Wang, Weikun Wu, Peiyu Zhang

***

Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins
Alessandro Contini

***

Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study
Junmei Wang

***

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like Protease (3CLpro) Structure: Virtual Screening Reveals Velpatasvir, Ledipasvir, and Other Drug Repurposing Candidates
Yu Wai Chen, Chin-Pang Yiu, and Kwok-Yin Wong

***

Homology Models of Coronavirus 2019-nCoV 3CLpro Protease
Martin Stoermer

***

Molecular Docking Study of Novel COVID-19 Protease with Low Risk Terpenoides Compounds of Plants
Neda Shaghaghi

***

Want the latest stories delivered to your inbox each month?